| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/12/2006 | CN1802360A 1,2,4-oxadiazole benzoic acid compounds |
| 07/06/2006 | WO2006071184A1 Aryl sulphonamide modulators |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | WO2006069808A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 07/06/2006 | WO2006069685A1 Substituted oxyarenes |
| 07/06/2006 | WO2006069656A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 07/06/2006 | WO2006055578A3 Asymmetric synthesis of (-)-agelastatin a |
| 07/06/2006 | US20060148864 Treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders |
| 07/06/2006 | US20060148863 E.g., 3-[5-(2-Chloro-pyridin-3-yl)-[1,2,4]oxadiazol-3-yl]-benzoic acid; treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders |
| 07/06/2006 | CA2592852A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 07/06/2006 | CA2592430A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
| 07/05/2006 | CN1798742A Novel biaromatic compounds which activate ppar [upsilon] pharmaceutical compsns |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | CA2592092A1 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/28/2006 | CN1261419C Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| 06/22/2006 | WO2006066126A2 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts |
| 06/22/2006 | WO2006065277A2 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064189A1 Oxadiazole derivatives as dgat inhibitors |
| 06/22/2006 | US20060135770 PARP inhibitors |
| 06/22/2006 | US20060135570 Cyclic sulfamides for inhibiton of gamma-secretase |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2591033A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | CA2588162A1 Oxadiazole derivatives as dgat inhibitors |
| 06/21/2006 | EP1670807A1 Fluorescent labeled sphingosines |
| 06/21/2006 | EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity |
| 06/21/2006 | EP1670749A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 06/21/2006 | EP1670463A2 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/15/2006 | WO2006062224A1 Carboxamide derivative |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | CA2268954C Oxadiazoles, processes for their preparation and their use as medicaments |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | US20060122397 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor; neurological disorders, psychiatric disorders, acute and chronic pain |
| 06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases |
| 06/07/2006 | EP1663234A1 Piperazine derivatives for the treatment of hiv infections |
| 06/07/2006 | CN1784454A Electroluminescent metallo-supramolecules with terpyridine-based groups |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/06/2006 | US7056932 Heterocyclyl substituted 1-alkoxy acetic acid amides |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006030211A3 Acyclic sulphonamides |
| 06/01/2006 | WO2006017214A3 Inhibitors of histone deacetylase |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 05/31/2006 | EP1661899A1 Organic electroluminescent device |
| 05/31/2006 | EP1660467A2 Aminofurazan compounds as protein kinase inhibitors |
| 05/31/2006 | EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives |
| 05/31/2006 | EP1659863A2 Pesticidally active phenol derivatives |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053122 Brain disorders; central nervous system disorders; anxiolytic agents; analgesics; sleep disorders |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7052783 Also triazine and 2H-tetrazole tetramers; electron transporting layers for electroluminescence devices |
| 05/25/2006 | US20060111359 enzyme inhibitor for treating sleep disorders |
| 05/24/2006 | EP1658285A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658273A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | CN1257257C 1,3,4-diazole additives for lubricants |
| 05/23/2006 | CA2301189C Non-steroidal ligands for the estrogen receptor |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2005086871A3 Compounds, compositions and methods for inhibiting or treating hiv-1 |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/17/2006 | EP1656361A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/11/2006 | WO2006050435A1 Heterocyclical chromophore architectures |
| 05/11/2006 | CA2584869A1 Heterocyclical chromophore architectures |
| 05/11/2006 | CA2575764A1 Diaryl ureas as cb1 antagonists |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094721 Sulfonamides as potassium channel blockers |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | US20060093551 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
| 05/04/2006 | CA2583681A1 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists |
| 05/03/2006 | EP1652843A1 Amide derivatives |
| 05/03/2006 | EP1651642A1 Pna monomer and precursor |
| 05/03/2006 | CN1768047A Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers. |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 04/27/2006 | WO2006044682A1 Compounds for nonsense suppression, and methods for their use |
| 04/27/2006 | WO2006044359A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 04/27/2006 | WO2006044133A1 Active ketone inhibitors of tryptase |
| 04/27/2006 | WO2006043539A1 Light-emitting compound, light-emitting polymer compound and light-emitting device |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089365 Heterocyclic compounds useful as nurr-1 activators |
| 04/27/2006 | US20060089357 Novel compounds and compositions as cathepsin inhibitors |
| 04/27/2006 | CA2583177A1 Compounds for nonsense suppression, and methods for their use |
| 04/26/2006 | EP1153922B1 Heterodiazinone derivatives |
| 04/26/2006 | CN1764708A Electron transport agents for organic electronic devices |
| 04/26/2006 | CN1764652A Ethynyl containing electron transport agents and their use in organic luminescent devices |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/19/2006 | EP1383729A4 Peptide deformylase inhibitors |